Zoetis Appoints Iris Knobloch to its Board of Directors
Zoetis (ZTS) has appointed Iris Knobloch to its Board of Directors, with the appointment effective December 1, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Knobloch brings deep expertise in consumer strategy, digital transformation, international leadership, and global board experience to the Zoetis Board
Ms. Knobloch has served as President of the Festival de
"We are delighted to welcome Iris Knobloch to the Zoetis Board of Directors. Iris brings a rare combination of strengths: deep expertise in consumer strategy, extensive digital transformation and technology experience, and a disciplined approach to brand stewardship across global markets," said Kristin Peck, Chief Executive Officer of Zoetis. "Her experience leading businesses through meaningful transitions and navigating diverse regulatory environments will add meaningful perspective as we face evolving industry dynamics, explore new ways to connect with pet owners and continue to provide our innovative products to customers across the globe."
"We are pleased to welcome Iris to the Zoetis Board of Directors. The Board is committed to supporting the company’s strategy to innovate and deliver solutions that meet the evolving needs of its customers. Iris brings a global point of view shaped by decades of experience across media and consumer businesses, a track record of effective board service and a deep understanding of evolving consumer behavior that will be an asset to our Board," said Michael McCallister, Zoetis Board Chair.
Earlier in her career, Ms. Knobloch was responsible for Time Warner's International Relations and Strategic Policy for
"I am honored to be joining the Zoetis Board of Directors at such a compelling moment for the company. With a strong legacy as the leader in animal health, I was drawn to the strength of its strategy, commitment to innovation and the quality of its leadership," said Iris Knobloch. "I look forward to working with the Board to support the company as it explores new and innovative ways to continue creating value for customers and the animals in their care."
With Ms. Knobloch's appointment, Zoetis will increase the size of its Board of Directors from 12 to 13 members, effective as of December 1, 2026.
About Zoetis
Zoetis is the world’s leading animal health company, driven by a singular purpose: to nurture our world and humankind by advancing care for animals. With a legacy of nearly 75 years, Zoetis continues to pioneer ways to predict, prevent, detect, and treat animal illness, supporting veterinarians, livestock producers, and pet owners in over 100 countries. We integrate deep scientific expertise, data-driven R&D, advanced manufacturing, and commercial excellence to deliver meaningful innovation across medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions. Guided by our vision to be the most trusted and valued animal health company, Zoetis is committed to setting new standards for the future of animal care through innovation, customer obsession, and purpose-driven colleagues. To learn more, visit Zoetis.com.
ZTS-COR
ZTS-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20261013131007/en/
Media Contacts:
Jennifer Albano
1-862-399-0810 (o)
jennifer.albano@zoetis.com
Laura Panza
1-973-975-5176 (o)
laura.panza@zoetis.com
Investor Contacts:
Mathieu Aussermeier
1-862-460-0181 (o)
mathieu.aussermeier@zoetis.com
Nick Soonthornchai
1-973-443-2792 (o)
nick.soonthornchai@zoetis.com
Source: Zoetis Inc.